Estados financieros detallados de Anavex Life Sciences Corp. (AVXL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.36, AVXL presenta beneficios negativos (P/E no significativo) y un ROE del -21.11%. La capitalización bursátil es de $219M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $7.3M | $10.7M | $13.3M | $22.3M | $25.2M | $33.0M | $37.9M | $43.7M | $41.8M | $37.6M |
| Generales y Administrativos | $8.3M | $5.0M | $6.0M | $6.8M | $5.9M | $9.0M | $13.1M | $12.0M | $11.0M | $13.8M |
| Gastos Operativos | $14.9M | $15.5M | $19.2M | $28.8M | $31.1M | $42.0M | $51.0M | $55.8M | $52.9M | $51.4M |
| Beneficio Operativo | 0 | 0 | 0 | 0 | -$31.1M | -$42.0M | -$51.0M | -$55.8M | -$52.9M | -$51.4M |
| EBITDA | -$15.0M | -$15.6M | -$19.1M | -$28.9M | -$31.1M | -$37.6M | -$47.6M | -$46.5M | -$43.0M | -$46.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $964000 | 0 | 0 |
| Beneficio Antes de Impuestos | -$14.7M | -$13.4M | -$17.4M | -$26.2M | -$30.6M | -$37.6M | -$47.6M | -$47.5M | -$43.0M | -$46.4M |
| Impuestos | $29615 | $59607 | $72746 | $82181 | -$4.4M | $268000 | $358000 | 0 | 0 | 0 |
| Beneficio Neto | -$14.7M | -$13.5M | -$17.5M | -$26.3M | -$26.3M | -$37.9M | -$48.0M | -$47.5M | -$43.0M | -$46.4M |
| BPA | $-0.42 | $-0.33 | $-0.39 | $-0.54 | $-0.45 | $-0.54 | $-0.62 | $-0.60 | $-0.52 | $-0.54 |
| BPA Diluido | $-0.42 | $-0.33 | $-0.39 | $-0.54 | $-0.45 | $-0.54 | $-0.62 | $-0.60 | $-0.52 | $-0.54 |
| Acciones en Circulación (Diluidas) | $35.2M | $40.8M | $44.7M | $48.9M | $58.2M | $69.8M | $76.9M | $79.8M | $83.5M | $85.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$10.8M | -$6.8M | -$6.5M | -$6.5M |
| EBITDA | -$6.5M | -$5.7M | -$6.5M | -$3.2M |
| Beneficio Neto | -$9.8M | -$5.7M | -$5.3M | -$3.2M |
| BPA | $-0.11 | $-0.06 | $-0.06 | $-0.03 |
| BPA Diluido | $-0.11 | $-0.06 | $-0.06 | $-0.03 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $9.2M | $27.4M | $22.9M | $22.2M | $29.2M | $152.1M | $149.2M | $151.0M | $132.2M | $102.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $79347 | $9748 | $1.9M | $2.6M | $4.8M | $9.1M | $3.2M | $2.7M | $2.4M | $809000 |
| Inventario | 0 | 0 | 0 | -$2.6M | 0 | $16365 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $9.4M | $27.8M | $24.3M | $25.3M | $34.5M | $161.6M | $152.7M | $154.4M | $135.6M | $103.8M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $9.5M | $27.8M | $24.4M | $25.3M | $34.5M | $161.6M | $152.7M | $154.4M | $135.6M | $103.8M |
| Cuentas por Pagar | $3.1M | $3.6M | $3.0M | $3.5M | $4.0M | $4.7M | $3.8M | $4.3M | $9.6M | $4.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.2M | $3.6M | $3.9M | $5.0M | $7.3M | $10.8M | $10.2M | $12.5M | $15.3M | $8.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $3.2M | $3.6M | $3.9M | $5.0M | $7.3M | $10.8M | $10.2M | $12.5M | $15.3M | $8.9M |
| Reservas | -$78.0M | -$91.5M | -$108.9M | -$133.4M | -$159.7M | -$197.6M | -$245.6M | -$293.1M | -$336.1M | -$382.4M |
| Patrimonio Neto | $6.3M | $24.3M | $20.5M | $20.3M | $27.2M | $150.8M | $142.5M | $141.9M | $120.3M | $94.9M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$9.2M | -$27.4M | -$22.9M | -$22.2M | -$29.2M | -$152.1M | -$149.2M | -$151.0M | -$132.2M | -$102.6M |
| Capital Circulante | $6.3M | $24.2M | $20.4M | $20.3M | $27.2M | $150.8M | $142.5M | $141.9M | $120.3M | $94.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $102.6M | $131.7M | $127.4M | $118.3M |
| Activos Totales | $103.8M | $133.0M | $128.8M | $120.1M |
| Pasivos Totales | $8.9M | $6.4M | $7.1M | $7.7M |
| Patrimonio Neto | $94.9M | $126.6M | $121.7M | $112.4M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$14.7M | -$13.5M | -$17.3M | -$26.3M | -$26.3M | -$37.9M | -$48.0M | -$47.5M | -$43.0M | -$46.4M |
| Amortizaciones | $1252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $5.1M | $4.1M | $5.5M | $6.4M | $4.9M | $8.2M | $18.4M | $16.4M | $9.4M | $11.5M |
| Cambio en Capital Circulante | $640068 | $382808 | -$846674 | $1.3M | $116518 | -$706000 | $5.4M | $2.5M | $2.8M | -$4.2M |
| Flujo de Caja Operativo | -$9.2M | -$9.0M | -$12.6M | -$18.5M | -$21.3M | -$30.4M | -$24.2M | -$27.8M | -$30.8M | -$39.0M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$9.2M | -$9.0M | -$12.6M | -$18.5M | -$21.3M | -$30.4M | -$24.2M | -$27.8M | -$30.8M | -$39.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$8.6M | -$7.2M | -$4.4M | -$13.5M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.6M | -$7.2M | -$4.4M | -$13.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.7M | $1.1M | 0 | -$16.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +8.7% | -29.7% | -50.7% | +0.1% | -44.2% | -26.6% | +1.0% | +9.5% | -7.8% |
| Crecimiento BPA (anual) | | +21.4% | -18.2% | -38.5% | +16.7% | -20.0% | -14.8% | +3.2% | +13.3% | -3.8% |
| Cambio en Acciones (anual) | | +16.2% | +9.3% | +9.5% | +19.0% | +19.9% | +10.2% | +3.7% | +4.6% | +2.2% |
| Crecimiento FCF (anual) | | +2.4% | -39.5% | -47.2% | -14.9% | -42.7% | +20.2% | -14.6% | -10.9% | -26.7% |
| Tasa Impositiva Efectiva | -0.2% | -0.4% | -0.4% | -0.3% | 14.2% | -0.7% | -0.8% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.26 | $-0.22 | $-0.28 | $-0.38 | $-0.37 | $-0.44 | $-0.32 | $-0.35 | $-0.37 | $-0.46 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $35.2M | $40.8M | $44.7M | $48.9M | $58.2M | $69.8M | $76.9M | $79.8M | $83.5M | $85.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -21.11% |
| Rentabilidad sobre capital invertido | -27.25% |
| Rentabilidad sobre activos | -20.01% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 15.62 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -8.64 | -12.55 | -6.62 | -5.85 | -10.11 | -33.24 | -16.65 | -10.92 | -10.92 | -16.48 |
| P/VC | 20.23 | 6.97 | 5.62 | 7.62 | 9.72 | 8.31 | 5.57 | 3.68 | 3.94 | 8.00 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |